Recycling the purpose of old drugs to treat ovarian cancer
The main challenge in ovarian cancer treatment is the management of recurrences. Facing this scenario, therapy selection is based on multiple factors to define the best treatment sequence. Target therapies, such as bevacizumab and polymerase (PARP) inhibitors, improved patient survival. However, des...
| Main Author: | |
|---|---|
| Other Authors: | , , |
| Format: | article |
| Language: | eng |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10216/145250 |
| Country: | Portugal |
| Oai: | oai:repositorio-aberto.up.pt:10216/145250 |